Novo Nordisk

Novo Nordisk’s Obesity Drug Trial Results Sparks Sharp Market Selloff

Business Pen
[stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk (NYSE: NVO) has spent years building its reputation around treatments for diabetes and obesity, so investors have...

Hims & Hers Health Down Sharply as Novo Nordisk Files Suit Over Wegovy Pill Alternative

Business Pen
[stock_market_widget type=”card” template=”basic2″ assets=”HIMS” realtime=”true” api=”yahoo-finance”] Hims & Hers Health (NYSE: HIMS) shares dropped sharply by more than 25% at market open today. This plunge...

Competition Tests Novo Nordisk’s Grip on Weight-Loss Drug Market

Business Pen
[stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk A/S (NYSE: NVO) surprised investors this week by warning that its sales may decline this year, marking...

Novo Nordisk Shares Surge Nearly 10% on Oral Wegovy Approval

Business Pen
[stock_market_widget type=”card” template=”basic” color=”#5679FF” assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk A/S (NYSE: NVO, CPH: NOVO-B) opened trading over 9% higher after U.S. regulators cleared an oral...

Alzheimer’s Drug Trial Failure Sends Novo Nordisk Stock Tumbling

Business Pen
[stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk A/S (NASDAQ: NVO) recently encountered a notable setback that sent ripples through its stock price and raised...

Subscribe to Newsletter